PTTG2
PTTG2 (pituitary tumour-transforming 2) encodes Securin-2, a member of the securin family. It is predicted to act as a cysteine-type endopeptidase inhibitor and to participate in homologous chromosome segregation. Browse Assay Genie's current range of PTTG2 research reagents below, or read on for the biology behind the target.
PTTG2 encodes Securin-2, a protein that belongs to the securin family. According to the NCBI Gene summary, which is based on predictions provided by the Alliance of Genome Resources, the PTTG2 protein is expected to enable cysteine-type endopeptidase inhibitor activity and to be involved in homologous chromosome segregation. These assignments are predicted rather than experimentally established, so they are best read as a starting framework for study and not as settled function.
Securin-2 is annotated as being located in the cytoplasm and as active in the nucleus. UniProt lists its subcellular locations as cytoplasm and nucleus. Researchers studying the PTTG2 gene or the Securin-2 protein will therefore usually need to consider both compartments when designing localisation or expression experiments.
The official HGNC name, pituitary tumour-transforming 2, places the gene alongside related securin-family genes. PTTG1, the related pituitary tumour-transforming gene, and PTTG1IP, a PTTG1-interacting protein, are useful points of comparison when characterising PTTG2. Because no detailed UniProt function annotation is available for Securin-2, work on this target benefits from careful controls and from comparison with better-characterised family members.
PTTG2 is predicted to be involved in homologous chromosome segregation, making it a candidate for studies of how securin-family proteins contribute to this process.
The predicted cysteine-type endopeptidase inhibitor activity of Securin-2 makes it relevant to investigations of protease regulation within the securin family.
As a securin family member, PTTG2 offers a basis for comparison with PTTG1 when examining how related proteins differ in role and expression.
Securin-2 is reported in both the cytoplasm and the nucleus, which makes it a useful subject for localisation and compartment-specific analysis.
PTTG2 encodes Securin-2. It is predicted to enable cysteine-type endopeptidase inhibitor activity and to be involved in homologous chromosome segregation. These functions are computational predictions, and no curated UniProt function annotation is currently provided for this protein.
The approved HGNC symbol is PTTG2 and the approved name is pituitary tumour-transforming 2. UniProt names the protein Securin-2. No alternative aliases or previous symbols are listed in the data used for this page.
UniProt lists the subcellular locations of Securin-2 as the cytoplasm and the nucleus. The NCBI Gene summary similarly predicts it to be located in the cytoplasm and active in the nucleus. It belongs to the securin family.
Securin-family and PTTG-related targets that are useful for comparison with PTTG2.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NZH5; product specifications from Assay Genie datasheets.